Hydroxychloroquine in COVID-19 widespread use despite unproven benefit

Hydroxychloroquine in COVID-19 widespread use despite unproven benefit

Saved in:

Bibliographic Details
Main Author:	Pranav Ish
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-01-01
Series:	Indian Journal of Rheumatology
Online Access:	http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=2;spage=213;epage=213;aulast=
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19
by: George G. Zhanel, et al.
Published: (2021-01-01)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
by: Takashi Watari, et al.
Published: (2023-05-01)

The pharmaceutical suitcase trade and the need for multisectoral regulation-unproven COVID-19 (Ivermectin and HCQ remedies unmask an insidious health danger in a Caribbean Island)
by: Sandeep Bhupendra Maharaj, et al.
Published: (2024-12-01)

Usefulness of hydroxychloroquine for COVID-19: Does answer lie in timing to start?
by: Mohan Gurjar, et al.
Published: (2020-01-01)

Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19
by: Aliede E. in ‘t Veld, et al.
Published: (2021-01-01)

COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
by: Awan K. Rahman, et al.
Published: (2020-01-01)

Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety
by: Alain Cornet, et al.
Published: (2021-04-01)

Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine
by: Latarissa IR, et al.
Published: (2025-01-01)

“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency.
by: NICOLA SGHERZA, et al.
Published: (2020-10-01)

COVID-19 and osteoarticular tuberculosis: Challenges and perspectives from a developing nation
by: Karthikeyan P Iyengar, et al.
Published: (2021-01-01)

Knowledge on hydroxychloroquine prescription and attitude toward its use in COVID-19 – A survey-based study among doctors
by: T P Afra, et al.
Published: (2021-01-01)

Granulomatosis with polyangiitis and COVID-19 pneumonia
by: Arvind Nune, et al.
Published: (2022-01-01)

Exploring the Role of News Outlets in the Rise of a Conspiracy Theory: Hydroxychloroquine in the Early Days of COVID-19
by: Robert Dickinson, et al.
Published: (2024-11-01)

Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients
by: Seyed Parsa Eftekhar, et al.
Published: (2021-01-01)

Hydroxychloroquine-induced auditory toxicity
by: Abhishek Patil, et al.
Published: (2020-01-01)

Rheumatologists’ perspective on hydroxychloroquine guidelines
by: Anca D Askanase, et al.
Published: (2020-10-01)

Hydroxychloroquine’s Early Impact on Cone Density
by: Tomoko Ueda-Consolvo, et al.
Published: (2021-01-01)

Young patient diagnosed with hydroxychloroquine intoxication
by: Luis Olmos Gutiérrez, et al.
Published: (2017-05-01)

Persistent pandemic demand for elective orthopedic surgery despite patient anxieties regarding COVID-19 in at-risk populations
by: Caitlin Barrett, et al.
Published: (2024-12-01)

Serial rotational thromboelastography (ROTEM) in mechanically ventilated patients with COVID-19 demonstrates hypercoagulopathy despite therapeutic heparinization
by: Peter Rhee, et al.
Published: (2022-10-01)

The Psychological Benefits of COVID-19 Vaccination
by: My Nguyen
Published: (2021-01-01)

Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite emergence of the alpha variant
by: Najib M Rahman, et al.
Published: (2021-01-01)

Anti‐retinal Autoantibodies in Hydroxychloroquine Eye Toxicity
by: Samuel D. Good, et al.
Published: (2025-01-01)

Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System
by: Justin Baroukhian, et al.
Published: (2024-12-01)

A Case of Severe Hydroxychloroquine-Induced Retinal Toxicity in a Patient with Recent Onset of Renal Impairment: A Review of the Literature on the Use of Hydroxychloroquine in Renal Impairment
by: Rajen Tailor, et al.
Published: (2012-01-01)

Missing IUD Despite Threads at the Cervix
by: Andrew L. Atkinson, et al.
Published: (2014-01-01)

Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo
by: Wieslawa H. Dragowska, et al.
Published: (2024-12-01)

Widespread pustular rash in an elderly patient
by: Cristina Grechin, MBBS, MRCPI, et al.
Published: (2025-01-01)

Biosensors and their widespread impact on human health
by: Dinesh Bhatia, et al.
Published: (2024-01-01)

Advanced pentosan polysulfate sodium maculopathy with low cumulative exposure and hydroxychloroquine use
by: Elena Flester, et al.
Published: (2024-12-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01)

SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’
by: Pierre Kory, et al.
Published: (2020-09-01)

Exogenous ketone therapy does not protect brain tissue after moderate-sized intracerebral hemorrhage despite signs of early neurological benefit.
by: Noam H Sander, et al.
Published: (2024-01-01)

COVID-19 Variants and Vaccine Benefits-Risks Balance
by: Abdulsalam Al-Ani .
Published: (2021-12-01)

Hydroxychloroquine-induced hyperpigmentation in a patient with anti-synthetase syndrome
by: Claúdia Brazão, et al.
Published: (2024-10-01)

Widespread potential for streamflow leakage across Brazil
by: José Gescilam S. M. Uchôa, et al.
Published: (2024-11-01)

Widespread Arterial Thrombosis after ChAdOx1 nCov-19 Vaccination
by: Giorgio Berlot, et al.
Published: (2022-01-01)

Short-term survivors with brain metastases have modest benefits from focal and systemic therapies and remain frequent despite improving treatment landscape
by: M. Czogalla, et al.
Published: (2025-03-01)

Erdosteine in Chronic Obstructive Pulmonary Disease – Evidence and Current Role
by: Yash Kedia, et al.
Published: (2024-11-01)

Hydroxychloroquine-induced Sweet’s Syndrome: A Case Report and Literature Review
by: Gustavo Almeida-Silva, et al.
Published: (2025-01-01)